Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

Patent examiners can make mistakes. Patent office clerks can misfile paperwork and cause procedural errors. The software tools, document formats like DOCX, and the IT systems your application passes ...

Huonslab, a subsidiary of Huons Global and a major player in recombinant human hyaluronidase-based biologics Sub-Q delivery, announced on Nov. 11 that it has completed patent filing and examination ...

At times, the cycling patent news cycle feels intense and a little relentless. A patent for exciting new components or some ...

Encouraged and abetted by free riders who would benefit unfairly from others’ work, well-intentioned lawmakers and judicial ...

The US Patent and Trademark Office (USPTO ... USPTO DIRECTOR MAINTAINS SIGNIFICANT FLEXIBILITY IN DIRECTOR REVIEW PROCEDURES Consistent with the interim process, the Director retains significant ...

What started off as a dice roll of a new practice group at Russ August & Kabat has turned into the breadwinner of the ...

The Himachal Pradesh High Court bench of Ms. Justice Jyotsna Rewal Dua, affirmed that 'patent illegality' in the award calls ...

A recent executive order prompted the US Patent and Trademark Office to publish a new guideline ... the claim limitations ...